Trial NCT01238029

View at ClinicalTrials.gov 
Org. Study IDs: 0907-002

Last trial update was posted on 2014-11-21

MeSH Interventions

Capecitabine Lapatinib Vinorelbine

MeSH Conditions

Breast Neoplasms

Other Conditions

Failure or Contraindication of Trastuzumab Therapy First or Second Line Therapy HER2 Positive Metastatic Breast Cancer

Stopping Reasons

new methods of treatment, no more patients appilicable for study

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID